Capcium has assembled a best-in-class management team with extensive encapsulation and pharmaceutical expertise to spearhead its mission to become the first choice of North America’s leading pharmaceutical, nutraceutical and licensed cannabis producers for their value-added manufacturing needs.
Executive Chairman & Co-Founder
Since co-founding Capcium in 2015, Mitch has been a key driver of Capcium’s vision, providing strategic leadership on financing and growth opportunities as well as fostering an entrepreneurial spirit in the Company. A lifelong entrepreneur, Mitch brings over 25 years of senior management experience in related manufacturing industries and capital markets expertise to Capcium. Prior to co-founding Capcium, Mitch was President of GI Sportz Inc., the largest global manufacturer, and distributor of paintball products where he spearheaded its growth strategy culminating with its successful sale to private equity and spun out its encapsulation expertise to Capcium to service the cannabis and pharmaceutical industries. Prior to GI Sportz, Mitch was one of the leading health care bankers in Canada and Head of Investment Banking at Orion Securities (which was acquired by Macquarie Capital Markets), where he led dozens of financings and provided merger & acquisition advice to entrepreneurial companies in the health care and technology sectors. Mitch holds civil and common law degrees (BCL and LLB) from McGill University.
Chief Executive Officer
Sylvain Duvernay holds a Bachelor’s degree in Business Administration and a Certificate in International Trade. He has over 20 years of experience in international business. Sylvain filled the position of Senior Vice-President for Strides Arcolab Ltd. (now Mylan), a pharmaceutical generic product company involved in softgel, injectable and solid dose manufacturing. He led its Canadian operations as well as its business development in the United States. In 2008, Sylvain was behind the acquisition of the Bristol-Myers Squibb facility in Candiac where he developed a business model for the injectable business and acted as the President and CEO for the new entity, Uman Pharma Inc. The company was sold to Pharmascience in November 2014 (now Pharmascience Global Injectables).
Chief Financial Officer
As Capcium’s CFO, Nicolas Giroux leads the finance department and oversees all financial operations, including operational strategy, reporting, forecasting, cash management, financing, risk management, IT and M&A as well as corporate development and business optimizations. Nicolas previously acted as CFO for of GI Sportz Inc., the largest global manufacturer, and distributor of paintball products, where he participated in all aspects of the business and helped spin out its encapsulation expertise to Capcium to service the cannabis and pharmaceutical industries. Prior to joining GI Sportz inc., Nicolas was a Senior Director for almost 10 years in the Recovery & Reorganization department at a major international accounting firm, and one of the largest in Quebec and Canada, and specialized in turnarounds for a wide range of industries, as well as focusing on both public and private company audits. Nicolas holds a bachelor’s degree in commerce, a major degree in accounting and is a Chartered Professional Accountant (CPA-CA).
General Counsel & Corporate Secretary
Alexander MacAngus is the General Counsel & Corporate Secretary of Capcium Inc. with oversight and responsibility for all legal and regulatory matters affecting the business, investor relations, and corporate secretary to the Board of Directors. Prior to joining Capcium, Alex held the position of General Counsel for GI Sportz Inc., the largest global manufacturer, and distributor of paintball products. Alex previously worked at a top AMLaw 100 firm in New York City, as well as serving in the legal departments for several large public and private companies and holds civil, common law and juris doctor degrees from the University of Ottawa. Alex is called to the Quebec and Ontario provincial bar associations.
Vice-President of Compliance & Regulatory Affairs
Alain Bérubé is Capcium’s Vice-President of Compliance & Regulatory Affairs. Alain is responsible for overall compliance, quality assurance, quality control, validation, and regulatory affairs activities. Alain holds a B.Sc. degree in microbiology and a M.Sc. degree in Virology. Over the last 29 years, he has held various Quality leadership positions in the pharmaceutical industry, both in the innovator and the generic sectors. Alain was involved in several pharmaceutical company startups over the course of his career, assuming leadership roles and building Quality teams and systems and managing several successful inspections by Health Canada and the FDA. Prior to joining Capcium, Alain was the Vice President Compliance & Regulatory Affairs at Uman Pharma (developer and manufacturer of generic oncology injectable products for Canadian, the US, and international markets) as well as Senior Director Quality Assurance at Axcan Pharma with responsibilities in Canada, the US, and Europe.
Vice-President of Strategic Business Development
Bringing nearly 20 years of experience in the pharmaceutical industry, Alain’s expertise in business development, portfolio strategy, and technology assessment/acquisition is a strong addition to the Capcium management team. His early career was as Director Business development at Montreal startup ConjuChem Biotechnologies. This was followed by his role as BD Director with generic specialty injectables Uman Pharma, another startup where he succeeded in out-licensing the entire portfolio of development products to US-based and global pharmaceutical partners. Alain contributed to the company’s growth and success which ultimately led to its acquisition by Pharmascience. Most recently, Alain was Director of Commercial Operations of Jubilant HollisterStier’s Montreal facility where he was responsible for new client and product integrations as well as management of the existing client base. Alain studied engineering at the University of Waterloo and has an MBA from The Richard Ivey School of Business.